FDA Approves Multaq® for Patients with Atrial Fibrillation or Atrial Flutter

BREAKING NEWS

Multaq(R), the much anticipated replacement for amiodarone, just received FDA approval.

Read the press release: FDA Approves Multaq® for Patients with Atrial Fibrillation or Atrial Flutter

Bookmark and Share

Related Posts

One Response to “FDA Approves Multaq® for Patients with Atrial Fibrillation or Atrial Flutter”

  1. Does anyone have an estimate of timing on approvals for Multaq in Canada now that the FDA has approved?

Discussion Area - Leave a Comment